DRUGS related term(s) Crime; Pharmaceuticals
Addresses
State of the Union: President Trump, S645–S649 [24FE], H2287–H2295 [24FE]
Amendments
Armed Forces: remove from unauthorized hostilities against Venezuela (S.J. Res. 98), S165, S172 [13JA], S222 [14JA]
Bills and resolutions
Abortion: reaffirm safety of medication abortion and preempt State restrictions on dispensing medication abortion (see H.R. 8734), H3346 [11MY]
Accelerating Access to Critical Therapies for ALS Act: reauthorize (see S. 4472), S2171 [30AP] (see H.R. 8205), H2824 [6AP]
Armed Forces: commend U.S. military action in Venezuela (see S. Res. 576), S115 [8JA]
——— furnish stellate ganglion block to members with post-traumatic stress disorder (see H.R. 8764), H3392 [12MY]
——— remove from unauthorized hostilities against Venezuela (see H. Con. Res. 68), H134 [7JA]
Bureau of Prisons: provide for civil commitment of persons who are danger to public safety (see H.R. 8452), H3067 [22AP]
Centers for Medicare & Medicaid Services: require Center for Medicare and Medicaid Innovation to test model implementing most-favored-nation drug pricing (see H.R. 7837), H2470 [5MR]
Children and youth: prohibit gender transition procedures on minors and impose civil penalties on persons who perform such procedures on minors (see S. 4426), S2128 [29AP] (see H.R. 8573), H3294 [29AP]
Colleges and universities: require that opioid overdose rescue kits be located at public institutions of higher education (see H.R. 8499), H3122 [27AP]
——— streamline process for institutions to research marijuana (see H.R. 8394), H2995 [20AP]
Controlled Substances Act: extend limitations period for certain offenses resulting in death or serious bodily injury (see S. 4209), S1614 [25MR]
Courts: establish Federal tort for harm to women caused by chemical abortion drugs (see S. 4066), S1009 [11MR] (see H.R. 7902), H2481 [12MR]
——— give Federal courts additional discretion to determine whether pretrial detention is appropriate for defendants charged with nonviolent drug offenses in Federal criminal cases (see S. 3960), S731 [2MR]
Crime: prevent importation of illicit pill press machines with intent to counterfeit substances (see S. 4446), S2170 [30AP] (see H.R. 7184), H1171 [21JA]
——— prohibit certain acts related to fentanyl, analogues of fentanyl, and counterfeit substances (see H.R. 8005), H2620 [19MR]
——— provide for death penalty for anyone who knowingly deals fentanyl to person who dies from use (see H.R. 8766), H3392 [12MY]
DEA: make permanent scheduling of benzimidazole-opioids known as nitazenes (see H.R. 7970), H2595 [18MR]
——— schedule synthetic 7-hydroxymitragynine as schedule I controlled substance (see H.R. 8000), H2620 [19MR]
Dept. of Agriculture: delay implementation of amendments to laws governing hemp production (see S. 3686), S257 [15JA] (see H.R. 7024), H717 [13JA]
——— maintain certain State and Tribal laws relating to hemp (see S. 4315), S1820 [16AP]
Dept. of Defense: improve access to certain medications under TRICARE program (see S. 4106), S1090 [17MR]
——— publish list of dietary supplement ingredients prohibited for use by members of Armed Forces (see S. 4626), S2443 [21MY] (see H.R. 8962), H3722 [21MY]
Dept. of Education: establish grant program to provide schools with opioid overdose reversal drugs and direct schools receiving Federal funds to report to certain Federal information systems any distribution of such drug (see H.R. 7994), H2620 [19MR]
——— provide grants for institutions of higher education to prevent alcohol and substance misuse (see H.R. 7019), H655 [12JA]
Dept. of HHS: adjust which engineered cyclic peptides are qualifying single source drugs relative to drug price negotiation program (see H.R. 8857), H3550 [15MY]
——— award grants to eligible entities to address maternal mental health conditions and substance use disorders relative to pregnant and postpartum individuals (see S. 4552), S2326 [18MY] (see H.R. 8811), H3529 [14MY]
——— carry out national campaign to increase awareness of importance of maternal vaccinations for health of pregnant and postpartum individuals and their children (see S. 4132), S1205 [18MR] (see H.R. 8024), H2621 [19MR] (see H.R. 8153), H2790 [27MR]
——— collect data and report to Congress on cost to Medicaid program from hospital and emergency room visits related to marijuana use (see S. 4345), S1840 [20AP]
——— ensure that Federally-qualified health centers are not required to pay more than 340B ceiling price for covered outpatient drugs at time of purchase (see H.R. 7391), H2040 [5FE]
——— ensure that women seeking chemical abortion are made aware of risks involved (see H.R. 7237), H1912 [23JA]
——— establish demonstration program to award grants to States to improve provision of recommended immunizations for children, adolescents, and adults through use of mobile vaccination units (see H.R. 7465), H2118 [10FE]
——— establish fair prices for prescription drugs (see H.R. 9040), H3735 [26MY]
——— establish interagency working group on peer-to-peer behavioral health programs for law enforcement officers and first responders (see H.R. 8493), H3091 [23AP]
——— establish program to develop innovative antimicrobial drugs targeting most challenging pathogens and most threatening infections (see H.R. 7352), H2029 [4FE]
——— establish program to support health care providers and pharmacies in providing discounted insulin products to uninsured individuals (see S. 4512), S2278 [13MY]
——— improve access to pre-exposure prophylaxis (PrEP) to reduce transmission of HIV (see S. 3990), S802 [4MR] (see H.R. 7853), H2471 [5MR]
——— issue guidelines for addressing nitazene overdoses (see H.R. 8192), H2821 [2AP]
——— make determinations of exclusivity periods for which licensed biological products are eligible (see S. 4332), S1821 [16AP]
——— modernize clinical trials and remove barriers for participation in clinical trials (see S. 4440), S2128 [29AP]
——— provide for appropriate cost-sharing for insulin products covered under private health plans (see S. 4512), S2278 [13MY]
——— provide funding for trained school personnel to administer drugs and devices for emergency treatment of known or suspected opioid overdose (see S. 3588), S89 [7JA]
——— release of documents, communications, and other information relating to most favored nation pricing agreements and other private or confidential drug pricing deals struck with manufacturers (see S. 4355), S1857 [21AP]
——— require community health centers to provide behavioral and mental health and substance use disorder services (see H.R. 8201), H2824 [6AP]
Dept. of Homeland Security: develop performance metrics relating to detection, deterrence, and seizure of fentanyl (see H.R. 8535), H3123 [27AP]
——— making continuing appropriations for certain employees and contractors of U.S. Customs and Border Protection and U.S. Immigration and Customs Enforcement in event of Government shutdown (see S. 3681), S257 [15JA]
——— require Science and Technology Directorate to work with DEA to develop greater capacity to detect, identify, and disrupt illicit substances, such as nitazenes, in very low concentrations (see H.R. 8022), H2621 [19MR]
Dept. of HUD: repeal Fair Housing Act provisions that allow landlords to deny housing to individuals with prior drug distribution convictions (see H.R. 7765), H2368 [3MR]
Dept. of Justice: establish grants to combat opioid trafficking (see H.R. 8818), H3530 [14MY]
——— provide direct hire authority to appoint qualified candidates to DEA positions in locations deemed necessary to support DEA mission (see H.R. 7413), H2094 [9FE]
Dept. of Labor: issue guidance and regulations regarding opioid overdose reversal medication and employee training (see S. 3812), S552 [10FE] (see H.R. 7479), H2118 [10FE]
——— provide States and local areas information on best practices to address effects of substance use disorder on workforce and provide grants for training related to treatment and prevention (see H.R. 8203), H2824 [6AP]
Dept. of Veterans Affairs: eliminate copayments for medicines relative to preventive health services (see S. 4217), S1668 [26MR]
——— establish Office of Novel Therapeutics within Veterans Health Administration (see S. 4220), S1668 [26MR]
——— expand access to Veterans Community Care Program to include certain veterans seeking mental health or substance-use services (see H.R. 8737), H3391 [12MY]
——— furnish stellate ganglion block to veterans with post-traumatic stress disorder (see H.R. 8763), H3392 [12MY]
——— improve schedule for rating disabilities (see H.R. 8066), H2675 [24MR]
——— make opioid overdose rescue medications available to veterans and their caregivers (see S. 3758), S442 [2FE]
——— modify Precision Medicine for Veterans Initiative (see H.R. 8115), H2776 [26MR]
——— transmit veteran’s history of opioid prescriptions to Community Care health care provider (see H.R. 8679), H3340 [7MY]
Depts. of Defense and Veterans Affairs: set maximum cost-sharing amount for prescription drugs for Armed Forces members and veterans and set maximum price for prescription drugs procured by Federal agencies (see H.R. 8667), H3340 [7MY]
Depts. of HHS and HUD: award grants to improve access to, develop, or expand, services that provide individuals with transportation to or from substance use disorder treatment or supportive services (see H.R. 8916), H3668 [20MY]
Depts. of HHS and State: formulate strategy to secure support from foreign countries, multilateral organizations, and others to facilitate development and commercialization of qualified pandemic or epidemic products (see H.R. 7879), H2476 [9MR]
Diseases and disorders: mitigate effects of coronavirus pandemic on incentives for development of orphan drugs (see H.R. 7693), H2327 [25FE]
——— protect against seasonal and pandemic influenza (see H.R. 8447), H3067 [22AP]
FDA: accelerate patient access to innovative medicines and clinical trials for life-threatening diseases by establishing reciprocal approval mechanism with trusted international regulatory authorities (see H.R. 7953), H2550 [17MR]
——— amend treatment of homeopathic drug products (see H.R. 7050), H892 [14JA]
——— clarify and affirm preemptive authority over dietary supplement regulation (see H.R. 7366), H2030 [4FE]
——— clarify process for denying certain petitions whose primary purpose is to delay approval of application submitted relative to certain drugs (see H.R. 8908), H3627 [19MY]
——— enhance ability of outsourcing facilities to mitigate drug shortages by allowing short-term period to continue supplying market after drug is in shortage (see H.R. 7528), H2217 [12FE]
——— enhance drug manufacturing amount information reporting (see H.R. 8339), H2959 [16AP]
——— establish new prohibited acts relative to dietary supplements (see S. 3797), S509 [5FE] (see H.R. 7407), H2041 [5FE]
——— expand certain authorities relative to recall of controlled substances to apply to all drugs (see H.R. 7980), H2596 [18MR]
——— improve regulation of abortion drugs by prohibiting approval of new drugs, preventing labeling changes of existing drugs, and limiting dispensing of drugs remotely, by mail, or telemedicine (see S. 3697), S290 [27JA]
——— provide for regulation of cannabinoid hemp products (see H.R. 7212), H1349 [22JA]
——— require drug labeling to include original manufacturer and supply chain information (see S. 3788), S509 [5FE] (see H.R. 8269), H2885 [14AP]
——— require manufacturers of dietary supplements to list dietary supplements (see S. 3677), S257 [15JA] (see H.R. 8370), H2994 [20AP]
——— require regulatory review of pharmaceutical products from Chinese entities (see S. 4327), S1821 [16AP]
——— respect scientific judgement that mifepristone is safe and effective and ensure access to lifesaving, time-sensitive medication abortion care in U.S. is equitable and based on science (see S. Res. 732), S2305 [14MY] (see H. Res. 1285), H3531 [14MY]
——— set forth limitations on exclusive approval or licensure of drugs designated for rare diseases or conditions (see S. 3716), S344 [28JA]
——— strengthen regulation of compounding pharmacies and outsourcing facilities (see S. 3794), S509 [5FE]
——— withdraw approval of mifepristone for termination of intrauterine pregnancy (see S. 4066), S1009 [11MR] (see H.R. 7902), H2481 [12MR]
Federal Railroad Administration: allow only U.S. citizens and permanent residents with reporting location in U.S. to operate trains crossing U.S. southern border and ensure that inspections are not unnecessarily delayed (see H.R. 8468), H3090 [23AP]
FTC: report to Congress on ability of minors to access fentanyl through social media platforms (see S. 3618), S161 [13JA]
GAO: conduct study and submit report on price-related compensation and payment structures in prescription drug supply chain (see S. 3751), S377 [29JA]
Government: prohibit Federal agencies from taking adverse action due to provision of business assistance to cannabis-related legitimate businesses (see H.R. 7987), H2596 [18MR]
Health: address high costs of health care services, prescription drugs, and health insurance coverage in U.S. (see H.R. 8840), H3531 [14MY]
——— end liability shield for vaccine manufacturers (see S. 3853), S578 [11FE]
——— provide private right of action for children and parents of children whose healthy body parts have been damaged by medical professionals practicing or participating in certain interventions (see H.R. 7651), H2258 [23FE]
Health care professionals: protect religious freedom of pharmacists choosing not to dispense or sell abortion-inducing drugs (see H.R. 8366), H2994 [20AP]
Immigration and Nationality Act: amend definition of aggravated felony to include certain serious drunk driving offenses (see S. 3584), S89 [7JA] (see H.R. 8302), H2924 [15AP]
Income: prohibit kickbacks to pharmacy benefit managers (see H.R. 7895), H2481 [12MR]
Information technology: modify requirements relating to prescription of controlled substances via Internet (see H.R. 6994), H615 [9JA]
Insulin: reduce price of insulin, require pharmacy benefit managers to pass-through manufacturer rebates for insulin products, and promote generic and biosimilar competition (see S. 4189), S1614 [25MR]
Insurance: ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care (see S. 4027), S915 [9MR]
——— require group health plans and health insurance issuers providing coverage for mental health and substance use disorder services to eliminate cost-sharing from pregnancy diagnosis to 1-year postpartum (see S. 3698), S290 [27JA] (see H.R. 7227), H1350 [22JA]
——— require out-of-pocket expenditures for drugs to count towards individual’s deductible and out-of-pocket maximum (see H.R. 8270), H2885 [14AP]
Law enforcement: focus limited Federal resources on most serious offenders by modifying sentencing guidelines for certain drug offenses (see S. 3959), S731 [2MR]
Medicaid: codify value-based purchasing arrangements and reforms relative to price reporting under such arrangements (see H.R. 7871), H2476 [9MR]
——— ensure adequate access to vaccines under Vaccines for Children program (see H.R. 8425), H3045 [21AP]
——— repeal budget neutrality requirement for certain demonstration projects (see H.R. 8234), H2830 [9AP]
Medicare: expand eligibility for incentives under health professional shortage area bonus program to practitioners furnishing mental health and substance use disorder services (see H.R. 7324), H1975 [3FE]
——— provide coverage for pre-exposure prophylaxis (PrEP) furnished by pharmacists (see H.R. 7189), H1171 [21JA]
——— require Medicare Payment Advisory Commission reports to Congress on arrangements with pharmacy benefit managers relative to prescription drug plans and Medicare Advantage prescription drug plans (see S. 3729), S377 [29JA]
——— require prescription drug plan sponsors of part D prescription drug plan that use formulary to include certain generic drugs and biosimilar biological products on such formulary (see H.R. 8143), H2789 [27MR]
——— require sponsors of prescription drug plans and Medicare Advantage organizations offering such plans under part D to include certain drugs and biosimilar biological products on formulary (see S. 4323), S1820 [16AP]
Methadone: revise Dept. of HHS Mandatory Guidelines for Federal Workplace Drug Testing Programs to include testing for methadone use and require Dept. of Transportation to include testing for methadone use in drug tests (see H.R. 7967), H2550 [17MR]
Middle East: modify interagency strategy to disrupt and dismantle narcotics production and trafficking and affiliated networks in Middle East (see H.R. 7180), H1171 [21JA]
National Fentanyl Awareness Day: designate (see S. Res. 704), S2129 [29AP] (see H. Res. 1234), H3295 [29AP]
NIH: establish National Institute for Biomedical Research and Development (see H.R. 7854), H2471 [5MR]
Organized Crime Drug Enforcement Task Forces: combat transnational organized crime and reduce availability of illicit narcotics in U.S. by using prosecutor-led, multi-agency approach to enforcement (see S. 4004), S881 [5MR]
Patient Protection and Affordable Care Act: ensure taxpayer funds for health insurance coverage are available only to U.S. citizens, nationals, or aliens lawfully present (see H.R. 7817), H2470 [5MR]
Pharmaceuticals: prohibit pharmacy benefit managers, insurers, and prescription drug or medical device wholesalers from being under common ownership with certain medical service providers (see S. 3822), S552 [10FE]
——— prohibit pharmacy benefit managers and pharmacies from being under common ownership (see S. 4509), S2277 [13MY] (see H.R. 8779), H3452 [13MY]
Public Health Service Act: prohibit treatment of biologic as biological product based solely on presence of protein that is clinically inactive component in such biologic (see H.R. 8630), H3330 [30AP]
Social Security: affirm importance to people of U.S. and express that it must be preserved, protected, and strengthened for current and future generations (see S. Res. 579), S115 [8JA]
States: increase compliance with Prescription Drug Monitoring Program (PDMP) requirements by veterinarians (see H.R. 8983), H3723 [21MY]
Tardive Dyskinesia Awareness Week: designate (see H. Res. 1265), H3342 [7MY]
Taxation: permit expenditures from health savings accounts, flexible spending arrangements, and health reimbursement arrangements for dietary supplements (see S. 4587), S2415 [20MY] (see H.R. 8933), H3669 [20MY]
Trump, President: impeachment (see H. Res. 1155), H2825 [6AP]
Venezuela: commend President Trump, Armed Forces, intelligence community, and Dept. of Justice for success of ‘‘Operation Absolute Resolve’’ (see H. Res. 998), H893 [14JA]
——— support arrest of Nicolas Maduro under Operation Absolute Resolve and assist Venezuelan people in their fight for freedom (see S. Res. 582), S162 [13JA]
Women: allow greater access to safe and effective oral contraceptive drugs intended for routine use and direct GAO to conduct study on Federal funding of contraceptive methods (see H.R. 8083), H2710 [25MR]
Messages
Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the U.S.: President Trump, S1838 [20AP], H2978 [20AP]
National Emergency Relative to U.S. Southern Border and Cartels and Other Transnational Organizations: President Trump, S159 [13JA], H691 [13JA]
Motions
Armed Forces: remove from unauthorized hostilities against Venezuela (S.J. Res. 98), S100 [8JA], S218 [14JA]
Remarks in House
Abortion: prohibit chemical abortions, H1342 [22JA]
Armed Forces: remove from unauthorized hostilities against Venezuela (H. Con. Res. 68), H1317–H1325 [22JA]
——— remove from unauthorized hostilities against Venezuela (H. Con. Res. 68), unanimous-consent request, H1157 [21JA]
——— remove from unauthorized hostilities against Venezuela (S.J. Res. 90), H608 [9JA], H912 [15JA]
Black, Randy: Mothers for Awareness and Prevention of Drug Abuse (organization) Leadership Award recipient, E400 [30AP]
Brammer, Bob: Mothers for Awareness and Prevention of Drug Abuse (organization) Leadership Award recipient, E401 [30AP]
Chesterfield County, VA: anniversary of Helping Addicts Recover Progressively (HARP) Program, E143 [20FE]
Dept. of Agriculture: modify definition of hemp, H697 [13JA]
Dept. of HHS: launch of White House Great American Recovery Initiative, H1984 [4FE]
Dept. of Transportation: prohibit funding to implement advanced impaired driving technology motor vehicle safety standard, H1297, H1298 [22JA]
Dept. of Veterans Affairs: authorize health care providers to provide recommendations and opinions to veterans regarding participation in State marijuana programs, H3504 [14MY]
——— interim rule relative to determining disability benefit eligibility, H2238 [23FE]
——— reimburse State homes for cost of, or furnish to State homes, certain costly medications provided to veterans who receive nursing home care in such State homes (H.R. 1970), H3298 [30AP]
——— stellate ganglion block treatment for post-traumatic stress disorder funding, H3537, H3538 [15MY]
——— support research into psychedelic-assisted therapies to treat post-traumatic stress disorder and depression, H3503 [14MY]
Domestic policy: lower cost of consumer products and increase affordability, H2548 [17MR]
FDA: publish final rule relative to nonclinical testing methods (S. 355), H941 [20JA]
Health: address high costs of health care services, prescription drugs, and health insurance coverage in U.S., H3554 [19MY]
Health care professionals: tribute to pharmacists, H1989 [4FE]
Immigration: secure U.S. borders and reform immigration policies, H709–H711, H713 [13JA]
Insurance: require group health plans and health insurance issuers providing coverage for mental health and substance use disorder services to eliminate cost-sharing from pregnancy diagnosis to 1-year postpartum (H.R. 7227), H2989 [20AP]
Medicare: assure pharmacy access and choice for beneficiaries (H.R. 4317), H928 [20JA]
——— establish improved Medicare for All national health insurance program (H.R. 3069), H111 [7JA]
Myers, Wayne: Pennsylvania Pharmacists Association Pharmacist of the Year award recipient, H2487 [16MR]
NIH: establish National Institute for Biomedical Research and Development (H.R. 7854), H2556 [18MR]
Pharmaceuticals: address overprescribing of antidepressants, H3719 [21MY]
——— improve services provided by pharmacy benefit managers, H2237 [23FE]
Tariff: terminate national emergency declared by President to institute tariffs relative to influx of illegal aliens and illicit drugs from Canada (H.J. Res. 72), H2154–H2161 [11FE]
——— terminate national emergency declared by President to institute tariffs relative to influx of illegal aliens and illicit drugs from Canada (H.J. Res. 72), unanimous-consent agreement, H2116 [10FE]
Taxation: strike provision of American Opportunity Tax Credit that denies credit to students with felony drug convictions, E334 [16AP]
Trump, President: condemn pardon of Juan O. Hernández, H3432, H3433 [13MY]
——— evaluation of administration, H1133 [21JA]
——— pardon of Juan O. Hernández, H2156 [11FE]
Venezuela: U.S. military and intelligence operation to capture Nicolas Maduro and his wife and extradite them to U.S. to face Federal drug, terrorism, and weapons charges, H137, H142, H148, H246 [8JA], H650–H654 [12JA]
Remarks in Senate
Armed Forces: remove from unauthorized hostilities against Venezuela (S.J. Res. 90), S56 [6JA]
——— remove from unauthorized hostilities against Venezuela (S.J. Res. 98), S4 [5JA], S64, S69 [7JA], S96–S100 [8JA], S123 [12JA], S186, S212–S218 [14JA], S233 [15JA]
——— remove from unauthorized hostilities against Venezuela (S.J. Res. 98), motion to proceed, S218 [14JA]
——— remove from unauthorized hostilities against vessels operating in Caribbean Sea or Eastern Pacific Ocean (S.J. Res. 100), S56–S61 [6JA]
Budget: create point of order against reconciliation legislation that does not lower out-of-pocket health care costs, S1906 [22AP]
——— establish deficit-neutral reserve fund relative to reducing price of prescription drugs through adoption of Most Favored Nation drug pricing, S1915, S1916 [22AP]
——— establish deficit-neutral reserve fund to study economic impact of confidential drug pricing agreements between Federal agencies and pharmaceutical manufacturers, S1917 [22AP]
Children and youth: prohibit gender transition procedures on minors and impose civil penalties on persons who perform such procedures on minors (S. 4426), S2294 [14MY]
Dept. of Defense: investigate military operations targeting alleged drug traffickers in Ecuador, S1930 [22AP]
Dept. of HHS: issue guidance on whether hospital emergency departments should implement fentanyl testing as routine procedure for patients experiencing overdose (S. 921), S459 [3FE], S1559, S1560 [23MR]
FDA: improve regulation of abortion drugs by prohibiting approval of new drugs, preventing labeling changes of existing drugs, and limiting dispensing of drugs remotely, by mail, or telemedicine (S. 3697), S292 [27JA]
——— restore in-person dispensing requirements for chemical abortion drugs, S284 [27JA]
Health: address health care affordability by establishing health savings accounts for out-of-pocket costs, increasing price transparency, and expanding access to safe and nutritious food, S1849 [21AP]
Immigration and Nationality Act: amend definition of aggravated felony to include certain serious drunk driving offenses (S. 3584), S149 [13JA]
Insulin: reduce price of insulin, require pharmacy benefit managers to pass-through manufacturer rebates for insulin products, and promote generic and biosimilar competition (S. 4189), S2092 [29AP]
Kansas City, KS: tribute to Kansas City Police Dept., Narcotics Unit and Task Force officers, S88 [7JA]
Medicare: assure pharmacy access and choice for beneficiaries, S1701 [13AP]
——— implementation of drug price negotiation program, S65 [7JA]
National Fentanyl Awareness Day: designate (S. Res. 704), S2089, S2109 [29AP]
Pharmaceuticals: improve services provided by pharmacy benefit managers, S1701 [13AP]
Senate: legislative priorities, S560 [11FE]
Social Security: affirm importance to people of U.S. and express that it must be preserved, protected, and strengthened for current and future generations (S. Res. 579), S119 [8JA]
Venezuela: U.S. military and intelligence operation to capture Nicolas Maduro and his wife and extradite them to U.S. to face Federal drug, terrorism, and weapons charges, S4 [5JA], S20, S56–S61 [6JA], S64–S70, S72–S87 [7JA], S96–S100, S105, S108 [8JA], S233 [15JA]
Reports filed
Combating Illicit Xylazine Act: Committee on the Judiciary (Senate) (S. 545), S1820 [16AP]
Dept. of HHS Guidance on Whether Hospital Emergency Departments Should Implement Fentanyl Testing as Routine Procedure for Patients Experiencing Overdose: Committee on Health, Education, Labor, and Pensions (Senate) (S. 921), S343 [28JA]
Restoring Confidence in the World Anti-Doping Agency Act: Committee on Commerce, Science, and Transportation (Senate) (S. 233) (S. Rept. 119–111), S625 [23FE]
Texts of
H. Con. Res. 68, remove Armed Forces from unauthorized hostilities against Venezuela, H1317 [22JA]
H.J. Res. 72, terminate national emergency declared by President to institute tariffs relative to influx of illegal aliens and illicit drugs from Canada, H2154 [11FE]
S. 921, issue Dept. of HHS guidance on whether hospital emergency departments should implement fentanyl testing as routine procedure for patients experiencing overdose, S1559 [23MR]
S. 3677, Dietary Supplement Listing Act, S259 [15JA]
S. 3797, Prohibiting Tianeptine and Other Dangerous Products Act, S512 [5FE]
S. 3959, Smarter Sentencing Act, S733 [2MR]
S. 3960, Smarter Pretrial Detention for Drug Charges Act, S735 [2MR]
S. Res. 576, commend U.S. military action in Venezuela, S117 [8JA]
S. Res. 579, affirm importance of Social Security to people of U.S. and express that it must be preserved, protected, and strengthened for current and future generations, S118 [8JA]
S. Res. 582, support arrest of Nicolas Maduro of Venezuela under Operation Absolute Resolve and assist Venezuelan people in their fight for freedom, S163 [13JA]
S. Res. 704, National Fentanyl Awareness Day, S2135 [29AP]
S. Res. 732, respect FDA scientific judgement that mifepristone is safe and effective and ensure access to lifesaving, time-sensitive medication abortion care in U.S. is equitable and based on science, S2309 [14MY]